导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.32% | 2117/4773 |
| 近一周 | -2.43% | 2138/5462 |
| 近一月 | -4.40% | 2440/5421 |
| 近一季 | -6.09% | 1988/5209 |
| 近半年 | -8.53% | 3358/4920 |
| 近一年 | 5.76% | 1551/4366 |
| 近两年 | 47.74% | 1549/2954 |
| 近三年 | 19.71% | 1478/2253 |
| 成立以来 | 103.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.32% 1313/4961 |
6.86% 2787/5312 |
- - |
- - |
| 2025 | 16.62% 2433/4813 |
-1.01% 2531/3635 |
-0.61% 2976/4076 |
16.30% 2674/4524 |
1.92% 1150/4813 |
| 2024 | 7.62% 1641/3463 |
-1.87% 1291/2808 |
-5.92% 1818/3014 |
15.42% 1720/3129 |
1.00% 1139/3463 |
| 2023 | 4.00% 250/2656 |
11.39% 339/2280 |
-1.34% 476/2385 |
-1.40% 515/2515 |
-4.02% 846/2655 |
| 2022 | -13.63% 334/2207 |
-8.69% 289/1919 |
-1.08% 1670/2016 |
-8.72% 220/2113 |
4.75% 510/2208 |
| 2021 | 20.94% 171/1822 |
2.60% 215/1255 |
6.48% 742/1330 |
9.04% 147/1466 |
1.52% 894/1822 |
| 2020 | 13.97% 799/1250 |
-4.53% 372/1028 |
12.49% 685/1067 |
6.65% 820/1164 |
-0.50% 1076/1184 |
| 2019 | 20.12% 670/1092 |
29.44% 274/754 |
-9.47% 657/804 |
-1.53% 662/850 |
4.09% 817/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华安中证低波动ETF VS. 长安沪深300非周期A(740101) |